BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8941926)

  • 1. ELK and LERK-2 in developing kidney and microvascular endothelial assembly.
    Daniel TO; Stein E; Cerretti DP; St John PL; Robert B; Abrahamson DR
    Kidney Int Suppl; 1996 Dec; 57():S73-81. PubMed ID: 8941926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LERK-2, a binding protein for the receptor-tyrosine kinase ELK, is evolutionarily conserved and expressed in a developmentally regulated pattern.
    Fletcher FA; Carpenter MK; Shilling H; Baum P; Ziegler SF; Gimpel S; Hollingsworth T; Vanden Bos T; James L; Hjerrild K
    Oncogene; 1994 Nov; 9(11):3241-7. PubMed ID: 7936648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligands for EPH-related tyrosine kinase receptors are developmentally regulated in the CNS.
    Carpenter MK; Shilling H; VandenBos T; Beckmann MP; Cerretti DP; Kott JN; Westrum LE; Davison BL; Fletcher FA
    J Neurosci Res; 1995 Oct; 42(2):199-206. PubMed ID: 8568920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells.
    Stein E; Cerretti DP; Daniel TO
    J Biol Chem; 1996 Sep; 271(38):23588-93. PubMed ID: 8798570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain.
    Kozlosky CJ; VandenBos T; Park L; Cerretti DP; Carpenter MK
    Cytokine; 1997 Aug; 9(8):540-9. PubMed ID: 9245480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eph family receptors and ligands in vascular cell targeting and assembly.
    Stein E; Schoecklmann H; Daniel TO
    Trends Cardiovasc Med; 1997 Nov; 7(8):329-34. PubMed ID: 21235905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hindbrain segments.
    Gale NW; Flenniken A; Compton DC; Jenkins N; Copeland NG; Gilbert DJ; Davis S; Wilkinson DG; Yancopoulos GD
    Oncogene; 1996 Sep; 13(6):1343-52. PubMed ID: 8808709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
    Holland SJ; Gale NW; Mbamalu G; Yancopoulos GD; Henkemeyer M; Pawson T
    Nature; 1996 Oct; 383(6602):722-5. PubMed ID: 8878483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genes encoding the eph-related receptor tyrosine kinase ligands LERK-1 (EPLG1, Epl1), LERK-3 (EPLG3, Epl3), and LERK-4 (EPLG4, Epl4) are clustered on human chromosome 1 and mouse chromosome 3.
    Cerretti DP; Lyman SD; Kozlosky CJ; Copeland NG; Gilbert DJ; Jenkins NA; Valentine V; Kirstein MN; Shapiro DN; Morris SW
    Genomics; 1996 Apr; 33(2):277-82. PubMed ID: 8660976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors.
    Beckmann MP; Cerretti DP; Baum P; Vanden Bos T; James L; Farrah T; Kozlosky C; Hollingsworth T; Shilling H; Maraskovsky E
    EMBO J; 1994 Aug; 13(16):3757-62. PubMed ID: 8070404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization and chromosomal localization of mouse Eplg2, a gene encoding a binding protein for the receptor tyrosine kinase elk.
    Fletcher FA; Renshaw B; Hollingsworth T; Baum P; Lyman SD; Jenkins NA; Gilbert DJ; Copeland NG; Davison BL
    Genomics; 1994 Nov; 24(1):127-32. PubMed ID: 7896266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
    Wang D; Lehman RE; Donner DB; Matli MR; Warren RS; Welton ML
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G1088-96. PubMed ID: 12016135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
    Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
    J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells.
    Kujoth GC; Robinson DF; Fahl WE
    Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
    EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
    Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.